Optical coherence tomography for evaluation of coronary stents in vivo

References

• Potkin BN, Bartorelli AL, Gessert JM et al. Coronary artery imaging with intravascular high-frequency ultrasound. Circulation 81(5), 1575–1585 (1990).
   PubMed Web of Science ®Google Scholar
• von Birgelen C, Hartmann M, Mintz GS et al. Remodeling index compared to actual vascular remodeling in atherosclerotic left main coronary arteries as assessed with long-term (> or =12 months) serial intravascular ultrasound. J. Am. Coll. Cardiol. 47(7), 1363–1368 (2006).
   Google Scholar
• Regar E, Ligthart J, Bruining N, van Soest G. The diagnostic value of intracoronary optical coherence tomography. Herz 36(5), 417–429 (2011).
   Google Scholar
• Imola F, Mallus MT, Ramazzotti V et al. Safety and feasibility of frequency domain optical coherence tomography to guide decision making in percutaneous coronary intervention. EuroIntervention 6(5), 575–581 (2010).
   Google Scholar
• Prati F, Di Vito L, Biondi-Zoccai G et al. Angiography alone versus angiography plus optical coherence tomography to guide decision-making during percutaneous coronary intervention: the Centro per la Lotta contro l’Infarto-Optimisation of Percutaneous Coronary Intervention (CLI-OPCI) study. EuroIntervention 8(7), 823–829 (2012).
   PubMed Web of Science ®Google Scholar
• Ozaki Y, Okumura M, Ismail TF et al. The fate of incomplete stent apposition with drug-eluting stents: an optical coherence tomography-based natural history study. Eur. Heart J. 31(12), 1470–1476 (2010).
   PubMed Web of Science ®Google Scholar
• Gutiérrez-Chico JL, Wykrzykowska J, Nüesch E et al. Vascular tissue reaction to acute malapposition in human coronary arteries: sequential assessment with optical coherence tomography. Circ. Cardiovasc. Interv. 5(1), 20–29, S1 (2012).
   PubMed Web of Science ®Google Scholar
• Gutiérrez-Chico JL, Regar E, Nüesch E et al. Delayed coverage in malapposed and side-branch struts with respect to well-apposed struts in drug-eluting stents: in vivo assessment with optical coherence tomography. Circulation 124(5), 612–623 (2011).
   PubMed Web of Science ®Google Scholar
• Tanigawa J, Barlis P, Dimopoulos K, Di Mario C. Optical coherence tomography to assess malapposition in overlapping drug-eluting stents. EuroIntervention 3(5), 580–583 (2008).
   Google Scholar
• Tanigawa J, Barlis P, Kaplan S, Goktekin OCD. Stent strut apposition in complex lesions using optical coherence tomography. Am. J. Cardiol. 98(Suppl. 1), 97M (2006).
   Google Scholar
• Matsumoto D, Shite J, Shinke T et al. Neointimal coverage of sirolimus-eluting stents at 6-month follow-up: evaluated by optical coherence tomography. Eur. Heart J. 28(8), 961–967 (2007).
   PubMed Web of Science ®Google Scholar
• Katoh H, Shite J, Shinke T et al. Delayed neointimalization on sirolimus-eluting stents: 6-month and 12-month follow up by optical coherence tomography. Circ. J. 73(6), 1033–1037 (2009).
   PubMed Web of Science ®Google Scholar
• Gutiérrez-Chico JL, van Geuns RJ, Koch KT et al. Paclitaxel-coated balloon in combination with bare metal stent for treatment of de novo coronary lesions: an optical coherence tomography first-in-human randomised trial, balloon first vs. stent first. EuroIntervention 7(6), 711–722 (2011).
   PubMed Web of Science ®Google Scholar
• Yao ZH, Matsubara T, Inada T, Suzuki Y, Suzuki T. Neointimal coverage of sirolimus-eluting stents 6 months and 12 months after implantation: evaluation by optical coherence tomography. Chin. Med. J. 121(6), 503–507 (2008).
   Google Scholar
• Gutiérrez-Chico JL, Jüni P, García-García HM et al. Long-term tissue coverage of a biodegradable polylactide polymer-coated biolimus-eluting stent: comparative sequential assessment with optical coherence tomography until complete resorption of the polymer. Am. Heart J. 162(5), 922–931 (2011).
   PubMed Web of Science ®Google Scholar
• Miyoshi N, Shite J, Shinke T et al. Comparison by optical coherence tomography of paclitaxel-eluting stents with sirolimus-eluting stents implanted in one coronary artery in one procedure – 6-month follow-up. Circ. J. 74(5), 903–908 (2010).
   PubMed Web of Science ®Google Scholar
• Inoue T, Shite J, Yoon J et al. Optical coherence evaluation of everolimus-eluting stents 8 months after implantation. Heart 97(17), 1379–1384 (2011).
   PubMedGoogle Scholar
• Tanigawa J, Barlis P, Dimopoulos K, Dalby M, Moore P, Di Mario C. The influence of strut thickness and cell design on immediate apposition of drug-eluting stents assessed by optical coherence tomography. Int. J. Cardiol. 134(2), 180–188 (2009).
   PubMed Web of Science ®Google Scholar
• Guagliumi G, Costa MA, Sirbu V et al. Strut coverage and late malapposition with paclitaxel-eluting stents compared with bare metal stents in acute myocardial infarction: optical coherence tomography substudy of the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial. Circulation 123(3), 274–281 (2011).
   PubMed Web of Science ®Google Scholar
• Guagliumi G, Sirbu V, Musumeci G et al. Strut coverage and vessel wall response to a new-generation paclitaxel-eluting stent with an ultrathin biodegradable abluminal polymer: Optical Coherence Tomography Drug-Eluting Stent Investigation (OCTDESI). Circ. Cardiovasc. Interv. 3(4), 367–375 (2010).
   PubMed Web of Science ®Google Scholar
• Guagliumi G, Sirbu V, Bezerra H et al. Strut coverage and vessel wall response to zotarolimus-eluting and bare-metal stents implanted in patients with ST-segment elevation myocardial infarction: the OCTAMI (Optical Coherence Tomography in Acute Myocardial Infarction) Study. JACC Cardiovasc. Interv. 3(6), 680–687 (2010).
   PubMed Web of Science ®Google Scholar
• Liu Y, Imanishi T, Kubo T et al. Assessment by optical coherence tomography of stent struts across side branch. Comparison of bare-metal stents and drug-elution stents. Circ. J. 75(1), 106–112 (2011).
   Google Scholar
• Serruys PW, Ormiston JA, Onuma Y et al. A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods. Lancet 373(9667), 897–910 (2009).
   PubMed Web of Science ®Google Scholar
• Serruys PW, Onuma Y, Ormiston JA et al. Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes. Circulation 122(22), 2301–2312 (2010).
   PubMed Web of Science ®Google Scholar
• Kawamori H, Shite J, Shinke T et al. Natural consequence of post-intervention stent malapposition, thrombus, tissue prolapse, and dissection assessed by optical coherence tomography at mid-term follow-up. Eur. Heart J. Cardiovasc. Imaging doi:10.1093/ehjci/jes299 (2013) (Epub ahead of print).
   Google Scholar
• Gonzalo N, Serruys PW, Okamura T et al. Relation between plaque type and dissections at the edges after stent implantation: an optical coherence tomography study. Int. J. Cardiol. 150(2), 151–155 (2011).
   PubMed Web of Science ®Google Scholar
• Gonzalo N, Serruys PW, Okamura T et al. Optical coherence tomography assessment of the acute effects of stent implantation on the vessel wall: a systematic quantitative approach. Heart 95(23), 1913–1919 (2009).
   PubMed Web of Science ®Google Scholar
• Shin ES, Garcia-Garcia HM, Okamura T et al. Comparison of acute vessel wall injury after self-expanding stent and conventional balloon-expandable stent implantation: a study with optical coherence tomography. J. Invasive Cardiol. 22(9), 435–439 (2010).
   PubMedGoogle Scholar
• Kume T, Okura H, Miyamoto Y et al. Natural history of stent edge dissection, tissue protrusion and incomplete stent apposition detectable only on optical coherence tomography after stent implantation – preliminary observation. Circ. J. 76(3), 698–703 (2012).
   PubMed Web of Science ®Google Scholar
• Kawamori H, Shite J, Shinke T et al. The ability of optical coherence tomography to monitor percutaneous coronary intervention: detailed comparison with intravascular ultrasound. J. Invasive Cardiol. 22(11), 541–545 (2010).
   Google Scholar
• Porto I, Di Vito L, Burzotta F et al. Predictors of periprocedural (type IVa) myocardial infarction, as assessed by frequency-domain optical coherence tomography. Circ. Cardiovasc. Interv. 5(1), 89–96, S1 (2012).
   Google Scholar
• Tanaka A, Imanishi T, Kitabata H et al. Lipid-rich plaque and myocardial perfusion after successful stenting in patients with non-ST-segment elevation acute coronary syndrome: an optical coherence tomography study. Eur. Heart J. 30(11), 1348–1355 (2009).
   PubMed Web of Science ®Google Scholar
• Yonetsu T, Kakuta T, Lee T et al. Impact of plaque morphology on creatine kinase-MB elevation in patients with elective stent implantation. Int. J. Cardiol. 146(1), 80–85 (2011).
   Google Scholar
• Lee T, Kakuta T, Yonetsu T et al. Assessment of echo-attenuated plaque by optical coherence tomography and its impact on post-procedural creatine kinase-myocardial band elevation in elective stent implantation. JACC Cardiovasc. Interv. 4(5), 483–491 (2011).
   Google Scholar
• Lee T, Yonetsu T, Koura K et al. Impact of coronary plaque morphology assessed by optical coherence tomography on cardiac troponin elevation in patients with elective stent implantation. Circ. Cardiovasc. Interv. 4(4), 378–386 (2011).
   Google Scholar
• Suzuki Y, Ikeno F, Koizumi T et al. in vivo comparison between optical coherence tomography and intravascular ultrasound for detecting small degrees of in-stent neointima after stent implantation. JACC Cardiovasc. Interv. 1(2), 168–173 (2008).
   Google Scholar
• Jamil Z, Tearney G, Bruining N et al. Interstudy reproducibility of the second generation, Fourier domain optical coherence tomography in patients with coronary artery disease and comparison with intravascular ultrasound: a study applying automated contour detection. Int. J. Cardiovasc. Imaging 29(1), 39–51 (2013).
   Google Scholar
• Okamura T, Gonzalo N, Gutiérrez-Chico JL et al. Reproducibility of coronary Fourier domain optical coherence tomography: quantitative analysis of in vivo stented coronary arteries using three different software packages. EuroIntervention 6(3), 371–379 (2010).
   Google Scholar
• Barlis P, Regar E, Serruys PW et al. An optical coherence tomography study of a biodegradable vs. durable polymer-coated limus-eluting stent: a LEADERS trial sub-study. Eur. Heart J. 31(2), 165–176 (2010).
   PubMed Web of Science ®Google Scholar
• Gutiérrez-Chico JL, van Geuns RJ, Regar E et al. Tissue coverage of a hydrophilic polymer-coated zotarolimus-eluting stent vs. a fluoropolymer-coated everolimus-eluting stent at 13-month follow-up: an optical coherence tomography substudy from the RESOLUTE All Comers trial. Eur. Heart J. 32(19), 2454–2463 (2011).
   PubMed Web of Science ®Google Scholar
• Terashima M, Rathore S, Suzuki Y et al. Accuracy and reproducibility of stent-strut thickness determined by optical coherence tomography. J. Invasive Cardiol. 21(11), 602–605 (2009).
   PubMed Web of Science ®Google Scholar
• Gonzalo N, Garcia-Garcia HM, Serruys PW et al. Reproducibility of quantitative optical coherence tomography for stent analysis. EuroIntervention 5(2), 224–232 (2009).
   Google Scholar
• Kubo T, Imanishi T, Kitabata H et al. Comparison of vascular response after sirolimus-eluting stent implantation between patients with unstable and stable angina pectoris: a serial optical coherence tomography study. JACC Cardiovasc. Imaging 1(4), 475–484 (2008).
   PubMed Web of Science ®Google Scholar
• Murata A, Wallace-Bradley D, Tellez A et al. Accuracy of optical coherence tomography in the evaluation of neointimal coverage after stent implantation. JACC Cardiovasc. Imaging 3(1), 76–84 (2010).
   PubMed Web of Science ®Google Scholar
• Templin C, Meyer M, Müller MF et al. Coronary optical frequency domain imaging (OFDI) for in vivo evaluation of stent healing: comparison with light and electron microscopy. Eur. Heart J. 31(14), 1792–1801 (2010).
   PubMed Web of Science ®Google Scholar
• Prati F, Zimarino M, Stabile E et al. Does optical coherence tomography identify arterial healing after stenting? An in vivo comparison with histology, in a rabbit carotid model. Heart 94(2), 217–221 (2008).
   PubMed Web of Science ®Google Scholar
• Xie Y, Takano M, Murakami D et al. Comparison of neointimal coverage by optical coherence tomography of a sirolimus-eluting stent versus a bare-metal stent three months after implantation. Am. J. Cardiol. 102(1), 27–31 (2008).
   PubMed Web of Science ®Google Scholar
• Yamamoto M, Takano M, Murakami D et al. The possibility of delayed arterial healing 5 years after implantation of sirolimus-eluting stents: serial observations by coronary angioscopy. Am. Heart J. 161(6), 1200–1206 (2011).
   PubMed Web of Science ®Google Scholar
• Nakazawa G, Granada JF, Alviar CL et al. Anti-CD34 antibodies immobilized on the surface of sirolimus-eluting stents enhance stent endothelialization. JACC Cardiovasc. Interv. 3(1), 68–75 (2010).
   PubMed Web of Science ®Google Scholar
• Nakano M, Vorpahl M, Otsuka F et al. Ex vivo assessment of vascular response to coronary stents by optical frequency domain imaging. JACC Cardiovasc. Imaging 5(1), 71–82 (2012).
   Google Scholar
• Takano M, Yamamoto M, Mizuno M et al. Late vascular responses from 2 to 4 years after implantation of sirolimus-eluting stents: serial observations by intracoronary optical coherence tomography. Circ. Cardiovasc. Interv. 3(5), 476–483 (2010).
   Google Scholar
• Gutiérrez-Chico JL, Räber L, Regar E et al. Tissue coverage and neointimal hyperplasia in overlap vs. non-overlap segments of drug-eluting stents 9–13 months after implantation: in vivo-assessment with optical coherence tomography. JACC Cardiovasc. Imaging (2012).
   Google Scholar
• Windecker S, Serruys PW, Wandel S et al. Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial. Lancet 372(9644), 1163–1173 (2008).
   PubMed Web of Science ®Google Scholar
• Stone GW, Lansky AJ, Pocock SJ et al.; HORIZONS-AMI Trial Investigators. Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction. N. Engl. J. Med. 360(19), 1946–1959 (2009).
   PubMed Web of Science ®Google Scholar
• Serruys PW, Silber S, Garg S et al. Comparison of zotarolimus-eluting and everolimus-eluting coronary stents. N. Engl. J. Med. 363(2), 136–146 (2010).
   PubMed Web of Science ®Google Scholar
• Finn AV, Joner M, Nakazawa G et al. Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization. Circulation 115(18), 2435–2441 (2007).
   PubMed Web of Science ®Google Scholar
• Ikenaga H, Ishihara M, Dai K, Nakama Y, Ohtani T. Mechanisms of very late stent thrombosis after drug-eluting stent implantation: findings from coronary angioscopy and optical coherence tomography. JACC Cardiovasc. Imaging 4(11), 1217–1219 (2011).
   Google Scholar
• Guagliumi G, Sirbu V, Musumeci G et al. Examination of the in vivo mechanisms of late drug-eluting stent thrombosis: findings from optical coherence tomography and intravascular ultrasound imaging. JACC Cardiovasc. Interv. 5(1), 12–20 (2012).
   PubMed Web of Science ®Google Scholar
• Ko YG, Kim DM, Cho JM et al. Optical coherence tomography findings of very late stent thrombosis after drug-eluting stent implantation. Int. J. Cardiovasc. Imaging 28(4), 715–723 (2012).
   PubMedGoogle Scholar
• Lee CW, Kang SJ, Park DW et al. Intravascular ultrasound findings in patients with very late stent thrombosis after either drug-eluting or bare-metal stent implantation. J. Am. Coll. Cardiol. 55(18), 1936–1942 (2010).
   Google Scholar
• Inoue K, Abe K, Ando K et al. Pathological analyses of long-term intracoronary Palmaz–Schatz stenting; is its efficacy permanent? Cardiovasc. Pathol. 13(2), 109–115 (2004).
   PubMed Web of Science ®Google Scholar
• Nakazawa G, Otsuka F, Nakano M et al. The pathology of neoatherosclerosis in human coronary implants bare-metal and drug-eluting stents. J. Am. Coll. Cardiol. 57(11), 1314–1322 (2011).
   PubMed Web of Science ®Google Scholar
• Yonetsu T, Kim JS, Kato K et al. Comparison of incidence and time course of neoatherosclerosis between bare metal stents and drug-eluting stents using optical coherence tomography. Am. J. Cardiol. 110(7), 933–939 (2012).
   Google Scholar
• Takano M, Yamamoto M, Inami S et al. Appearance of lipid-laden intima and neovascularization after implantation of bare-metal stents extended late-phase observation by intracoronary optical coherence tomography. J. Am. Coll. Cardiol. 55(1), 26–32 (2009).
   Google Scholar
• Kang SJ, Mintz GS, Akasaka T et al. Optical coherence tomographic analysis of in-stent neoatherosclerosis after drug-eluting stent implantation. Circulation 123(25), 2954–2963 (2011).
   PubMed Web of Science ®Google Scholar
• Onuma Y, Serruys PW, Perkins LE et al. Intracoronary optical coherence tomography and histology at 1 month and 2, 3, and 4 years after implantation of everolimus-eluting bioresorbable vascular scaffolds in a porcine coronary artery model: an attempt to decipher the human optical coherence tomography images in the ABSORB trial. Circulation 122(22), 2288–2300 (2010).
   PubMed Web of Science ®Google Scholar
• Xu C, Schmitt JM, Carlier SG, Virmani R. Characterization of atherosclerosis plaques by measuring both backscattering and attenuation coefficients in optical coherence tomography. J. Biomed. Opt. 13(3), 034003 (2008).
   PubMed Web of Science ®Google Scholar
• van Soest G, Goderie T, Regar E et al. Atherosclerotic tissue characterization in vivo by optical coherence tomography attenuation imaging. J. Biomed. Opt. 15(1), 011105 (2010).
   PubMedGoogle Scholar
• Tearney GJ, Waxman S, Shishkov M et al. Three-dimensional coronary artery microscopy by intracoronary optical frequency domain imaging. JACC Cardiovasc. Imaging 1(6), 752–761 (2008).
   PubMed Web of Science ®Google Scholar
• Tu S, Xu L, Ligthart J et al. in vivo comparison of arterial lumen dimensions assessed by co-registered three-dimensional (3D) quantitative coronary angiography, intravascular ultrasound and optical coherence tomography. Int. J. Cardiovasc. Imaging 28(6), 1315–1327 (2012).
   PubMed Web of Science ®Google Scholar
• Rieber J. [Intravascular imaging and its integration into coronary angiography]. Dtsch. Med. Wochenschr. 137(14), 726–731 (2012).
   Google Scholar
• Liu L, Gardecki JA, Nadkarni SK et al. Imaging the subcellular structure of human coronary atherosclerosis using micro-optical coherence tomography. Nat. Med. 17(8), 1010–1014 (2011).
   PubMed Web of Science ®Google Scholar
• Nadkarni SK, Pierce MC, Park BH et al. Measurement of collagen and smooth muscle cell content in atherosclerotic plaques using polarization-sensitive optical coherence tomography. J. Am. Coll. Cardiol. 49(13), 1474–1481 (2007).
   PubMedGoogle Scholar